Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 1,557 | 1,489 | 1,964 | 1,388 | 1,837 |
| Cost of Goods | 840 | 860 | 890 | 700 | 930 |
| Gross Profit | 710 | 1,030 | 1,100 | 670 | 900 |
| Operating Expenses | 1,570 | 1,600 | 1,570 | 1,460 | 1,660 |
| Operating Income | -13 | -111 | 394 | -72 | 177 |
| Interest Expense | 10 | 9 | 3 | 9 | 9 |
| Other Income | -7 | 400 | 19 | 1 | 2 |
| Pre-tax Income | -30 | 280 | 410 | -80 | 170 |
| Income Tax | -10 | 110 | 150 | -20 | 70 |
| Net Income Continuous | -23 | 116 | 255 | -57 | 105 |
| Net Income | $-23 | $116 | $255 | $-57 | $105 |
| EPS Basic Total Ops | -0.01 | 0.04 | 0.09 | -0.02 | 0.04 |
| EPS Basic Continuous Ops | -0.01 | 0.04 | 0.09 | -0.02 | 0.04 |
| EPS Diluted Total Ops | -0.01 | 0.04 | 0.09 | -0.02 | 0.04 |
| EPS Diluted Continuous Ops | -0.01 | 0.04 | 0.09 | -0.02 | 0.04 |
| EBITDA(a) | $47 | $-61 | $454 | $-22 | $207 |